Raymond James & Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $111M | Sell |
|
|||||
|
2024
Q2 | $169M | Buy |
|
|||||
|
2024
Q1 | $170M | Buy |
|
|||||
|
2023
Q4 | $125M | Sell |
|
|||||
|
2023
Q3 | $115M | Buy |
|
|||||
|
2023
Q2 | $151M | Buy |
|
|||||
|
2023
Q1 | $121M | Buy |
|
|||||
|
2022
Q4 | $108M | Sell |
|
|||||
|
2022
Q3 | $132M | Sell |
|
|||||
|
2022
Q2 | $157M | Buy |
|
|||||
|
2022
Q1 | $194M | Buy |
|
|||||
|
2021
Q4 | $209M | Buy |
|
|||||
|
2021
Q3 | $166M | Buy |
|
|||||
|
2021
Q2 | $148M | Buy |
|
|||||
|
2021
Q1 | $92.8M | Buy |
|
|||||
|
2020
Q4 | $96.2M | Buy |
|
|||||
|
2020
Q3 | $69.7M | Buy |
|
|||||
|
2020
Q2 | $24.9M | Buy |
|
|||||
|
2020
Q1 | $21.6M | Sell |
|
|||||
|
2019
Q4 | $35.8M | Buy |
|
|||||
|
2019
Q3 | $33.6M | Buy |
|
|||||
|
2019
Q2 | $24.7M | Buy |
|
|||||
|
2019
Q1 | $25.1M | Sell |
|
|||||
|
2018
Q4 | $21.8M | Buy |
|
|||||
|
2018
Q3 | $24.5M | Buy |
|
|||||
|
2018
Q2 | $19.9M | Sell |
|
|||||
|
2018
Q1 | $21M | Sell |
|
|||||
|
2017
Q4 | $18.4M | Sell |
|
|||||
|
2017
Q3 | $18M | Buy |
|
|||||
|
2017
Q2 | $19.2M | Buy |
|
|||||
|
2017
Q1 | $13.3M | Sell |
|
|||||
|
2016
Q4 | $20.7M | Sell |
|
|||||
|
2016
Q3 | $30.2M | Buy |
|
|||||
|
2016
Q2 | $18.3M | Sell |
|
|||||
|
2016
Q1 | $16.3M | Buy |
|
|||||
|
2015
Q4 | $12.6M | Buy |
|
|||||
|
2015
Q3 | $10.7M | Buy |
|
|||||
|
2015
Q2 | $3.55M | Sell |
|
|||||
|
2015
Q1 | $4.08M | Sell |
|
|||||
|
2014
Q4 | $4M | Buy |
|
|||||
|
2014
Q3 | $3.2M | Sell |
|
|||||
|
2014
Q2 | $2.85M | Buy |
|
|||||
|
2014
Q1 | $2.13M | Sell |
|
|||||
|
2013
Q4 | $2.03M | Buy |
|